Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000996738 | SCV000279276 | likely benign | not provided | 2020-02-18 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000549690 | SCV000410264 | benign | Hereditary sensory neuropathy-deafness-dementia syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000549690 | SCV000651308 | uncertain significance | Hereditary sensory neuropathy-deafness-dementia syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 136 of the DNMT1 protein (p.Arg136Cys). This variant is present in population databases (rs138841970, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with Beckwith-Wiedemann syndrome (PMID: 30165906). ClinVar contains an entry for this variant (Variation ID: 234461). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000996738 | SCV001151625 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | DNMT1: BP4, BS1 |
Ambry Genetics | RCV002321845 | SCV002631994 | likely benign | Inborn genetic diseases | 2019-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetics and Molecular Pathology Laboratory, |
RCV000625705 | SCV000599434 | uncertain significance | Beckwith-Wiedemann syndrome | no assertion criteria provided | research | This variant was identified in heterozygous form in 1 of 51 cases with Beckwith Wiedemann syndrome with loss of methylation at KCNQ1OT1 at Imprinting centre 2 on 11p15.5. The variant was maternally inherited. The variant frequency in dbSNP147 is 0.00028. |